Phenelzine in Biochemical-Recurrent Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prostate Cancer and Prostatic Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer
Prostate Cancer Prostatic Dis. 2020 Mar 03;[EPub Ahead of Print], ME Gross, DB Agus, TB Dorff, JK Pinski, DI Quinn, O Castellanos, P Gilmore, JC ShihFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.